12
防病之窗
ر
j࣬ኽʕशषԣછʕːί
2007-2008
ϋྼ݄ٙΌ
ഐࣨष
ߗ
ᖹਿᇞሜ
ݟ
ٙഐ
؈
ᜑͪdʕഐࣨषɛ
ʕ
ߗ
εᖹ೯͛ଟ
މ
8.32%
dᐼ
މߒࠇ
12
ຬɛdᐼᅰඎ
සϣΙ
ܓ
З֢˰
ޢ
ୋɚЗdЦ˰
ޢ
อ೯
ߗ
εᖹઃ
٫ɛᅰٙ
1/4
fᄿ
ߗع
ᖹ೯षଟ
މۆ
0.68%
dᐼ
ߒࠇ
Ϟ
1
ຬɛfவ݊ʕִ݁ୋɓϣʮක
ו
Ⴉίʕɽ೯
ତəᄿ
ߗع
ᖹഐࣨषɛf
ΌଢᇍఖlzdӊϋП
ࠇ
̈ତ
ڐ
5
ຬΤᄿ
ߗع
ᖹഐࣨष
ઃ٫iϾʕഐࣨष
ߗ
ᖹਿᇞሜ
ݟ
ᜑͪdΌഐࣨ
षઃ٫ʕᄿ
ߗع
ᖹଟ
މ
0.68
ĈdኽϤПၑᄿ
ߗع
ᖹഐ
ࣨषઃ٫Ϟ
ڐ
ຬɛf
͟ᄿ
ߗع
ᖹഐࣨष࿁˷
ה
ϞٙҤഐࣨɓᇞձɚ
ᇞᖹ
ي
ேପ͛
ߗ
ᖹdΪϤdઃ٫ϥɳଟֻֻ
ܘ
৷fί
ڢی
ᖑ೯ٙɓৎᄿ
ߗع
ᖹഐࣨषԫʕd
53
Зઃ٫ʕϞ
52
ɛίɧմlzᘱ̘˰fί˰㠛ᐼ
ԫඹబ
ޜ
Ըdν
؈
ᄿ
ߗع
ᖹഐࣨषʔঐՑ
છՓdɛᗳਗ਼੭ΫӚϞҤ͛९eࠦ࿁ഐࣨष˷
Ҽ˓ೌഄٙࣛ˾f¨Ϊ
މ
ɛᗳʊ
40
εϋӚϞႡ
̈อᖹəf©
結核病其實是可以治癒的
Ң㠛͛
௰ژ
อʮбٙʕഐࣨषԣ
ط
ٟึ൙ᄆ
ഐ
؈
ᜑͪdҢʮ͏࿁ഐࣨषՈϞෂ
ݑ
ʿ̙˸
ط
ᓹٙႩٝ
ܓ
Эd࿁ഐࣨषԣ
ط
ዚʿԶе൬ൢ
ᓙձ
ط
ᐕٙٝወଟЭd࿁ഐࣨषઃ٫աٟึൖٙ
ዄː
৷ܓ
f
dᒱ್৶ഐࣨe໘ᇫഐࣨഃʔՈϞෂ
ݑ
dШ
੬Ԉٙ٬ഐࣨٙɓԬᗳۨՈϞෂ
ݑ
f̥Ϟຈʕঐ
ݟ
̈ഐࣨഽٙ٬ഐࣨषɛʑՈϞෂ
ݑ
dவԬ
ઃ٫ίۗྔe͂ᄝᎾeɽᑊႭ༑ࣛdఌ
ث
ᄝՑ˼ɛ
ᑕɪఱ̙ঐிϓෂ
ݑ
f
ୋɚdৰˇᅰεᖹ
ߗ
ᖹഐࣨቋַʔฏ̮dഒɽε
ᅰഐࣨष̙݊˸
ط
ᓹٙfШც
ࠅ
੶ሜٙ݊dഐࣨष
͍ٙ࿏ֵ
ط
ᐕ̀ϞœЇŕ
ࡈ
˜ٙᐕd˲ც
ࠅ
ε၇ᖹ
ي
ᑌΥԴ͜dʑঐ࿏ֵ
ط
ᓹf˰
ޢ
㠛͛ଡ଼
ᔌ
މ
Ϥ̈ٙତ˾ഐࣨषછՓഄଫ
ࠅ
Ӌઃ٫ӊϣ
ᖹѩ
ࠅ
ίᔼਕɛࡰࠦൖɨ͜f
ܘ
εઃ٫Ⴠൖषઋ
א
Ϊᖹ
ي
ਓЪ͜ӷІ৾ᖹdӚঐՑ߅ኪᇍٙ
ط
ᐕd̙ঐኬ
ߗߧ
ᖹഽࣺٙପ͛dᄣ̋
ط
ᐕᗭ
ܓ
fୋ
ɧdҢጤॴձጤॴ˸ɪٙᔼᐕ㠛͛ዚd۬ᕄձ
̹۬ேணϞᏨ
طݟ
ᐕഐࣨषٙਖ਼
ژ
ዚdе൬
މ
ෂ
ݑ
٬ഐࣨઃ٫ԶҤഐࣨᖹۜձ˴
ࠅ
Ꮸ
ݟ
f
މ
̋੶࿁Όഐࣨष
ޥ
ઋٙ၍ଣd
ڭ
ᗇઃ٫Ց߅
ኪᇍٙ
ط
ᐕdʕശɛ͏ձෂ
ݑ
षԣ
جط
֛d٬ഐࣨઃ٫ʿဲЧઃ٫
ࠅ
ίഐࣨषԣ
ط
ዚ
ආБ୕ɓٙᏨ
ݟ
eຖኬʷᐕձ၍ଣf
ܝ௰
d̥Ϟഐࣨഽຈ෩˪Ꮸ
ݟ
яජٙ٬ഐࣨઃ
٫ʑϞෂ
ݑ
f٬ഐࣨઃ٫කટա͍ᖹ
طي
ᐕ
ŏЇŐ
ࡈ
ಂ
ܝ
dɓছఱʔՈϞෂ
ݑ
d̙˸ਞ̋
͍੬ٟึ
ݺ
ਗfٟึᏐ࿁ഐࣨषઃ٫ഗʚᗫᕿձ
ᚥdʔᏐ༈ൖഐࣨषɛf
Beware: the Tuberculosis Killer is Back: Killing 2-3 Patients a Minute
Although tuberculosis (TB) was successfully eradicated in developed countries, it is still prevalent in developing countries, e.g.,
Cambodia. The current problem is development of drug resistance, especially as there are no new antibiotics for TB during the last 40
years. The worst is there is not only a phenomenon of mutual enhancement for TB and Aids but also masking the typical manifestation
of TB: the mortality of patients with dual affliction are very much higher. In China, 120,000 (8.32%) TB patients have resistance to >1
antibiotic: ranked second in the world; 10,000 (0.68%) have pan-resistance: responsible for 1/4 of the world’s total. As resistance is
associated with high mortality, ensure prompt active treatment; the WHO recommends taking all 4 antibiotics concurrently for at least
6 months to prevent resistance: Note also: (1) Only those with positive TB bacilli smears in their phlegm are contagious (2) Treatment
must last for 6-8 months, lest bacterial resistance develops (3) In China, there are well-organized and free investigation and treatment
facilities for TB. Above all, as TB patients are normally non-infectious after 2-3 weeks’ treatment, they should not be stigmatized.